Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.
- DOI
- 10.1080/21645515.2016.1219809
- Published
- 2016 Dec
- Container
- Human vaccines & immunotherapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/21645515.2016.1219809,
title = {Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.},
author = {Ruiz-Palacios GM and Leroux-Roels G and Beran J and Devaster JM and Esen M and Launay O and McElhaney JE and van Essen GA and Benoit A and Claeys C and Dewé W and Durand C and Duval X and Falsey AR and Feldman G and Galtier F and Gervais P and Hwang SJ and McNeil S and Richardus JH and Trofa A and Oostvogels L and Influence65 study group},
year = {2016},
journal = {Human vaccines \& immunotherapeutics},
doi = {10.1080/21645515.2016.1219809},
url = {https://doi.org/10.1080/21645515.2016.1219809}
}RIS
TY - JOUR TI - Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis. AU - Ruiz-Palacios GM AU - Leroux-Roels G AU - Beran J AU - Devaster JM AU - Esen M AU - Launay O AU - McElhaney JE AU - van Essen GA AU - Benoit A AU - Claeys C AU - Dewé W AU - Durand C AU - Duval X AU - Falsey AR AU - Feldman G AU - Galtier F AU - Gervais P AU - Hwang SJ AU - McNeil S AU - Richardus JH AU - Trofa A AU - Oostvogels L AU - Influence65 study group PY - 2016 JO - Human vaccines & immunotherapeutics DO - 10.1080/21645515.2016.1219809 UR - https://doi.org/10.1080/21645515.2016.1219809 ER -
APA
GM, R., G, L., J, B., JM, D., M, E., O, L., JE, M., GA, V. E., A, B., C, C., W, D., C, D., X, D., AR, F., G, F., F, G., P, G., SJ, H., S, M., JH, R., A, T., L, O., & group, I. S. (2016). Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis.. Human vaccines & immunotherapeutics. https://doi.org/10.1080/21645515.2016.1219809
Source records
- pubmed · retrieved 2026-09-25T21:01:35.455Z